Key result
Cardiac glycosides (oral digoxin or digitoxin) decreased diastolic blood pressure during overnight sleep in healthy volunteers and heart failure patients, with no detectable effect during the day.
Why the study?
Do cardiac glycosides affect 24-h ambulatory blood pressure in healthy volunteers and patients with heart failure?
Do cardiac glycosides affect 24-h ambulatory blood pressure in healthy volunteers and patients with heart failure?
Cardiac glycosides lower diastolic blood pressure during overnight sleep in both healthy individuals and mild heart failure patients, likely due to changes in sympatho-vagal balance.
May lower nocturnal diastolic BP; leaves open relevance for 24-h ambulatory monitoring in heart failure.
Blood pressure effects of cardiac glycosides in humans have been infrequently reported. Although direct infusion of ouabain or digoxin causes vasoconstriction, indirect effects of cardiac glycosides may have the opposite effect, owing to changes in sympatho-vagal balance. This paper summarises three studies on the effects of cardiac glycosides on circadian blood pressure, utilizing automatic 24-h ambulatory blood pressure measurement (ABPM). In healthy volunteers, 10 days of oral digoxin or digitoxin caused decreases in diastolic blood pressure and heart rate during overnight sleep. No effect was detectable during daytime activities. In patients with heart failure (NYHA stage II), 7 days of oral digoxin also caused a decrease in diastolic blood pressure but only a small increase in systolic pressure during overnight sleep. Again, no effect was detectable during the day. Cardiac glycosides have significant effects on blood pressure, which only appear during overnight sleep, i.e. a phase when sympathetic background activity is lowest. Regular daytime activities may 'overwrite' these effects. Effects of cardiac glycosides on blood pressure may have therapeutic impact, depending on the stage of heart failure and concomitant diseases.
No takes yet. Share an insight, caveat, or question.
Großmann et al. (2001) conducted a review in Healthy volunteers and heart failure (NYHA stage II). Cardiac glycosides (oral digoxin or digitoxin) was evaluated on Circadian blood pressure (24-h ABPM). Cardiac glycosides (oral digoxin or digitoxin) decreased diastolic blood pressure during overnight sleep in healthy volunteers and heart failure patients, with no detectable effect during the day.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: